Your Article Summary
See Latest ArticlesManagement of hypertension in acute stroke
Expert Review of Cardiovascular Therapy , 06/12/09
Aiyagari V et al. – A review of the management of hypertension in acute stroke summaries the focus of recent pilot studies and the key controversies and questions.
Methods- Review of the management of hypertension in acute stroke
- Hypertension common seen in an acute stroke setting
- Although hypertension is the most important modifiable risk factor for both ischemic and hemorrhagic stroke, immediate management of elevated blood pressure in this setting is controversial
- Key questions: when to start lowering blood pressure; by how much to lower pressure; which pharmaceutical agents to use; whether to continue or stop previous antihypertensive medications
- Recent pilot studies may serve as a foundation for larger definitive studies
Related Articles
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 83%
Hypertension treatment and management concerns in the elderly
Aging Health, 10/07/09
Relevance Score: 83%
Practical strategies for management of hypertension in the elderly
Internet Source, 10/13/09
Relevance Score: 82%
Amlodipine/Valsartan Single-Pill Combination: A Review of its Use in the Management of Hypertension
American Journal of Cardiovascular Drugs, 10/08/09
Relevance Score: 82%
Management of hypertension in the elderly patient
Clinical Interventions in Aging, 10/01/09
Relevance Score: 82%
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Annual Progression of Coronary Calcification in Trials of Preventive Therapies
Archives of Internal Medicine, 12/14/09
Update on perioperative bridging in patients on chronic oral anticoagulation
Expert Review of Cardiovascular Therapy , 12/14/09
The role of flow-mediated dilatation in the evaluation and development of antiatherosclerotic drugs
Current Opinion in Lipidology, 12/14/09